Analytical Data
-
基因名
OTUD1
- Application
-
别名
DUBA7; OTDC1
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q5VV17
-
表达区间
Lys309~Ser481
-
分子量
23kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
OTUD1, a member of the ovarian tumor domain-containing protein family, has emerged as a significant focus of research due to its crucial role in regulating cellular ubiquitination processes. Ubiquitination, a post-translational modification, is fundamental for various cellular functions, including protein degradation, cell cycle regulation, and DNA repair mechanisms. Recent studies have indicated that OTUD1 functions as a deubiquitinating enzyme (DUB), removing ubiquitin moieties from target proteins and thereby influencing their stability and activity. This has implications in multiple physiological and pathological contexts, including cancer and neurodegenerative diseases, where dysregulation of ubiquitination pathways is frequently observed. Furthermore, OTUD1 is involved in the modulation of immune responses and has been linked to viral infections, underscoring its potential as a therapeutic target. Research into OTUD1 and its recombinant protein form has provided insights into its enzymatic mechanisms and interaction partners, paving the way for a deeper understanding of its biological significance and potential applications in targeted therapies. The ongoing exploration of OTUD1's functions and its role in cellular processes positions it as a promising candidate for further investigation in both basic and applied biomedical research.












